Method for treating acne

Details Method for treating acne Method for treating acne

1993-04-15

1997-12-16

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514559, 514859, A61K 3112, A61K 3120

Patent

active

056985932

ABSTRACT:
Nodulocystic and conglobate acne in humans can be alleviated by the oral administration of 13-cis-retinoic acid or a derivative thereof. The active ingredient is administered in a dosage of from about 1.5 to about 3 mg/kg of body weight per day for a period of from about two to about four weeks.

REFERENCES:
patent: 3729568 (1973-04-01), Kligman
patent: 3882244 (1975-05-01), Lee
patent: 3932665 (1976-01-01), Van Scott et al.
patent: 3934028 (1976-01-01), Lee
patent: 4322438 (1982-03-01), Peck
patent: 4487782 (1984-12-01), Nezick
patent: 4545977 (1985-10-01), Gaull
patent: 4677120 (1987-06-01), Parish et al.
Windholz et al., The Merck Index, 10th Ed. p. 1315, abstract No. 9021 (Tetracycline).
Sporn et al., The Retnoids, 1984, vol. 1, pp. 393-412.
Perry et al., "Isotretinoin: New therapy for severe acne", Clinical Pharmacy, Jan.-Feb. 1983, pp. 12-19.
Orfanos et al, "The Retnoids", Drugs: 1987, pp. 469-472.
Cunliffe et al, "Isotretinoin An Explanation for Its Long-Term Benefit", Dermatological, 1987, pp. 133-137.
Cunliffe et al, "Isotretinoin and Acne: A Long-Term Study", Dermatology Branch National Cancer Institutes, 1991, pp. 274-280.

Affiliated with

Also associated with

Rating

Method for treating acne does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating acne will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-206824